These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16477241)

  • 1. Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient.
    Moreau C; Debray D; Loriot MA; Taburet AM; Furlan V
    Transplantation; 2006 Feb; 81(3):487-8. PubMed ID: 16477241
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between omeprazole and tacrolimus in renal allograft recipients: a clinical-analytical study.
    Pascual J; Marcén R; Orea OE; Navarro M; Alarcón MC; Ocaña J; Villafruela JJ; Burgos FJ; Ortuño J
    Transplant Proc; 2005 Nov; 37(9):3752-3. PubMed ID: 16386527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
    Charlton M
    Hepatology; 2011 Jul; 54(1):3-5. PubMed ID: 21710471
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient.
    Quirós-Tejeira RE; Chang IF; Bristow LJ; Karpen SJ; Goss JA
    Pediatr Transplant; 2005 Dec; 9(6):792-6. PubMed ID: 16269053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic determinant of the drug interaction between tacrolimus and omeprazole.
    Zhao W; Fakhoury M; Maisin A; Baudouin V; Storme T; Deschênes G; Jacqz-Aigrain E
    Ther Drug Monit; 2012 Dec; 34(6):739-41. PubMed ID: 23042259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.
    Pea F; Tavio M; Pavan F; Londero A; Bresadola V; Adani GL; Furlanut M; Viale P
    Antivir Ther; 2008; 13(5):739-42. PubMed ID: 18771060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum concentration of tacrolimus after ingesting omeprazole: a pilot study.
    Peloso LJ; Faria PN; Bossolani MV; de Oliveira HB; Ferreira Filho SR
    Transplantation; 2014 Sep; 98(6):e63-4. PubMed ID: 25221905
    [No Abstract]   [Full Text] [Related]  

  • 8. Supra-therapeutic tacrolimus concentrations associated with concomitant nicardipine in pediatric liver transplant recipients.
    Hurst AL; Clark N; Carpenter TC; Sundaram SS; Reiter PD
    Pediatr Transplant; 2015 Jun; 19(4):E83-7. PubMed ID: 25850753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus toxicity due to drug interaction with mibefradil in a patient after liver transplantation.
    Ocran KW; Plauth M; Mai I; Lochs H
    Z Gastroenterol; 1999 Oct; 37(10):1025-8. PubMed ID: 10549098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tacrolimus hydrate (tacrolimus)].
    Matsuda J
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():465-8. PubMed ID: 15658364
    [No Abstract]   [Full Text] [Related]  

  • 11. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between FK 506 and diltiazem in an animal model.
    Regazzi MB; Iacona I; Alessiani M; Spada M; Vaccarisi S; Villani P; Molinaro M
    Transplant Proc; 1996 Apr; 28(2):1017-8. PubMed ID: 8623215
    [No Abstract]   [Full Text] [Related]  

  • 13. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results.
    Hermida J; Tutor JC
    Ther Drug Monit; 2009 Apr; 31(2):269-72. PubMed ID: 19258927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.
    Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ
    J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation.
    Goto M; Masuda S; Kiuchi T; Ogura Y; Oike F; Tanaka K; Uemoto S; Inui K
    J Pharmacol Exp Ther; 2008 May; 325(2):610-6. PubMed ID: 18252812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itraconazole-tacrolimus drug interaction.
    Cervelli MJ; Russ GR
    Ther Drug Monit; 2003 Aug; 25(4):483-4. PubMed ID: 12883234
    [No Abstract]   [Full Text] [Related]  

  • 18. Buccal vs. nasogastric tube administration of tacrolimus after pediatric liver transplantation.
    Goorhuis JF; Scheenstra R; Peeters PM; Albers MJ
    Pediatr Transplant; 2006 Feb; 10(1):74-7. PubMed ID: 16499591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
    Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty liver due to high levels of serum tacrolimus after liver transplantation.
    Tümgör G; Ankan C; Nart D; Kihiç M; Aydoğdu S
    Turk J Pediatr; 2007; 49(2):223-5. PubMed ID: 17907528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.